Evidence map›Paper›PMID 25552305›Full record

ArticleThe American journal of hospice & palliative care2016

Malignant Bowel Obstruction in Patients With Recurrent Ovarian Cancer.

Elizabeth Tran, Clayton Spiceland, Nicole P Sandhu, Aminah Jatoi

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in The American journal of hospice & palliative care, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03260647 (Risk Stratified Multidisciplinary Ambulatory Management of Malignant Bowel Obstruction), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03260647 completednot on this mapstarted 2017, after this paper: background citation

Risk Stratified Multidisciplinary Ambulatory Management of Malignant Bowel Obstruction (MAMBO) Program for Women With Advanced Gynecological Cancers

TypeobservationalSponsorUniversity Health Network, TorontoRan2017 to 2024Enrolled96ConditionsGynecologic CancerArmsManagement algorithm for Malignant Bowel Obstruction
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elizabeth TranDepartment of Medicine, Mayo Clinic, Rochester, MN, USA.
Clayton SpicelandDepartment of Medicine, Mayo Clinic, Rochester, MN, USA.
Nicole P SandhuDepartment of Medicine, Mayo Clinic, Rochester, MN, USA.
Aminah JatoiDepartment of Oncology, Mayo Clinic, Rochester, MN, USA jatoi.aminah@mayo.edu.
Mayo Clinic in Arizona · US

Funding

Mentoring and Research in Cancer Palliative CareK24CA131099 · NCI · MAYO CLINIC ROCHESTER · PI JATOI, AMINAH · 2008 to 2012
$873k
NCI NIH HHS K24 CA131099
6 · The paper itself

Abstract

We sought to report incidence, risk factors, and survival related to bowel obstruction in 311 ovarian cancer patients with recurrent disease. A total of 68 (22%) had a documented bowel obstruction during their cancer course, and 49 (16%) developed it after cancer recurrence. Surprisingly, 142 (45%) fit into an "unknown" category (3+ months of data lacking from last contact/death). No risk factors were identified; management included surgery (n = 21), conservative measures (n = 21), and other (n = 7). Documented bowel obstruction was not associated with a statistically significant reduction in survival after cancer recurrence. In conclusion, although bowel obstruction occurs in only a subgroup of patients with ovarian cancer and does not appear to detract from survival after cancer recurrence, limited end-of-life information may be resulting in an underestimation of incidence.

Indexed as

AdolescentAdultAgedAged, 80 and overFemaleHumansIncidenceIntestinal ObstructionMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingOvarian NeoplasmsPalliative CarePrognosisRisk FactorsYoung Adultbowel obstructionend of lifemorbidityovarian cancer

Identifiers

PMID25552305
PMCPMC4569524
OpenAlexW2313835449

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.